ABSTRACT
Although the associated ocular pathology to systemic lupus erythematosus is not infrequent, its manifestations and importance can be overlooked by rheumatologists and ophthalmologists. We present the case of a 44-year-old male with a history of systemic lupus erythematosus whose disease started with metamorphopsia and subjective alteration of the visual fields of both eyes, with a marked decrease in visual acuity, secondary to bilateral serous retinal detachment and optic neuropathy. He received systemic corticosteroids, biological therapy and posterior subtenon triamcinolone acetonide injections, showing an improvement in visual acuity. Ophthalmic manifestations should be considered a sign of systemic lupus erythematosus activity, therefore the treatment is essentially systemic, in combinationed with local coadjutant treatment.
Subject(s)
Lupus Erythematosus, Systemic , Optic Nerve Diseases , Retinal Detachment , Adult , Humans , Lupus Erythematosus, Systemic/complications , Lupus Erythematosus, Systemic/drug therapy , Male , Optic Nerve Diseases/diagnosis , Optic Nerve Diseases/etiology , Vision Disorders/etiology , Visual AcuityABSTRACT
Si bien la patología ocular asociada a lupus eritematoso sistémico no es infrecuente, sus manifestaciones e importancia pueden ser a veces pasadas por alto por reumatólogos y oftalmólogos. Se describe el caso de un varón de 44 años con antecedente de lupus eritematoso sistémico que inicia enfermedad con metamorfopsias y alteración subjetiva de campos visuales de ambos ojos, presentando disminución marcada de agudeza visual secundaria a desprendimiento de retina seroso bilateral y neuropatía óptica. Recibió tratamiento con corticoides sistémicos, terapia biológica e inyecciones subtenonianas posteriores de triamcinolona, presentando mejoría de la agudeza visual. Las manifestaciones oftálmicas deben ser consideradas como signo de actividad del lupus eritematoso sistémico, por ese motivo el tratamiento es esencialmente sistémico, asociado a tratamiento coadyuvante local.
Although the associated ocular pathology to systemic lupus erythematosus is not infrequent, its manifestations and importance can be overlooked by rheumatologists and ophthalmologists. We present the case of a 44-year-old male with a history of systemic lupus erythematosus whose disease started with metamorphopsia and subjective alteration of the visual fields of both eyes, with a marked decrease in visual acuity, secondary to bilateral serous retinal detachment and optic neuropathy. He received systemic corticosteroids, biological therapy and posterior subtenon triamcinolone acetonide injections, showing an improvement in visual acuity. Ophthalmic manifestations should be considered a sign of systemic lupus erythematosus activity, therefore the treatment is essentially systemic, in combinationed with local coadjutant treatment.
